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Monday, February 4, 2013 205aOur results constitute a notable contribution to the characterization of the
ssDNA-NucS interactions and more generally to the nucleotide excision repair
mechanism. The method we developed furthermore constitutes a powerful way
to probe DNA/protein intramolecular kinetics.
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Construct a Catalyst using the Beta-Peptide Bundle
John Chu.
Yale University, New Haven, CT, USA.
‘‘What I cannot create, I do not understand.’’ Richard Feynman, 1988.
Through the construction of an efficient catalyst using a non-natural material,
this research project aims to deepen our understanding of the structural and en-
ergetic features that control catalysis. We expect our findings to inform the
principles for the design and engineering of both proteinaceous enzymes and
artificial catalysts.
We set out to use beta-peptides - a unique yet virtually unexplored middle
ground between proteins and small molecules - to devise catalysts for the for-
mation or hydrolysis of glycosidic bonds. Beta-peptides are smaller and thus
synthetically more tractable than natural proteins; nevertheless, they can still
adopt higher order structures inaccessible to small molecules. For example,
the Schepartz Laboratory reported previously that the EYYK b-peptide self-
assembles into an octameric bundle that displays conformational flexibility
and thermodynamic properties similar to natural protein. We therefore build
our first generation design around the EYYK scaffold.
Each beta-peptide bundle will be characterize by three biophysical techniques.
In addition to structural information obtained by X-ray crystallography, two
novel assays that evaluate the beta-peptide bundles based on their substrate
binding affinity and reaction turnover rate will be carried out. Together these in-
formation provide details of the physical and chemical properties of the beta-
peptides to guide the iterative design - synthesis - characterization process.
The latest results of our first generation beta-peptide bundle, EYBK, will be
presented. The utility of two newly developed assays for monitoring binding
and turnover will also be discussed in the context of informing catalyst design.
1049-Plat
An Artificial Safranine Enzyme which Activates Chemotherapeutic
Prodrugs
Ronald L. Koder1, Gheevarghese Raju1, Joseph Brisendine1, Vikas Nanda2.
1The City College of New York, New York, NY, USA, 2Rutgers University,
Piscataway, NJ, USA.
Protein design has opened new boundaries in the past decade, particularly in the
area of designed enzymes capable of catalyzing reactions not yet observed in
nature. We report the design and synthesis of an artificial enzyme capable of
activating the class of nitroaromatic anticancer prodrugs typified by CB1954.
The enzyme utilizes a synthetic flavin analogue cofactor, p-methoxysafranine,
which has a reduction potential preoptimized for efficient nitroreduction.
Progress toward optimizing catalytic activity and determination of the three-di-
mensional struc-
ture of this novel
enzyme will also
be reported.1050-Plat
Redox Enzymology of Shewanella Oneidensis Cytochrome C Nitrite
Reductase
Evan T. Judd.
Boston University, Boston, MA, USA.
Shewanella oneidensis cytochrome c nitrite reductase (soNrfA), a dimeric en-
zyme that houses five c-type hemes per protomer, carries out the six-electron
reduction of nitrite and the two-electron reduction of hydroxylamine. Protein
film voltammetry (PFV) has previously been used to study the cytochrome c
nitrite reductase from Escherichia coli (ecNrfA) adsorbed to a graphite elec-
trode, revealing catalytic reduction of both nitrite and hydroxylamine substrates
by ecNrfA that is characterized by ‘boosts’ and attenuations in activity depend-
ing on the applied potential. Here, we use PFV to investigate the catalytic prop-
erties of soNrfA during both nitrite and hydroxylamine turnover and compare
those properties to ecNrfA. Distinct differences in both the electrochemical and
kinetic characteristics of soNrfA are observed, e.g., all detected electron trans-
fer steps are one-electron in nature, contrary to what has been observed in
ecNrfA. Additionally, we find evidence of substrate inhibition during nitrite
turnover and negative cooperativity during hydroxylamine turnover, neither
of which have previously been observed in any cytochrome c nitrite reductase.
Collectively these data provide evidence that during catalysis, potential path-
ways of communication exist between the individual soNrfA monomers com-
prising the native homodimer.1051-Plat
Vibrational Stark Effects in the Active Site of Ketosteroid Isomerase Point
to Large Electric Fields Driving Chemical Catalysis
Stephen D. Fried, Sayan Bagchi, Steven G. Boxer.
Stanford University, Palo Alto, CA, USA.
Enzymes are extraordinary catalysts that actuate nearly all biomolecular
processes with speed and specificity. Nevertheless, the physical origins of en-
zymes’ catalytic power remain elusive despite investigations of many enzymes’
mechanisms over the last half-century. Ketosteroid isomerase (KSI) is a small
and proficient enzyme - accelerating an isomerization reaction ~1 trillion-fold
over its intrinsic rate in water - that has been employed as a test system to ex-
amine the catalytic strategies at Nature’s disposal. Electrostatic interactions are
broadly purported to play an essential role in catalysis, but this proposal has yet
to be experimentally tested in a quantitative fashion. Toward this end, vibra-
tional Stark effect spectroscopy provides a toolkit to measure electric fields
in biomolecular environments. By measuring the vibrational Stark effect of
an intrinsic probe that mimics the reactive species of KSI’s catalytic cycle,
we found that KSI’s active site focuses an extremely large electric field onto
the scissile bond, potentially enabling its speedy chemical conversion through
electrostatic interactions. Moreover, we observed a strong correlation between
active site electric field and catalytic power across several KSI mutants. These
studies are building toward a highly reductionist picture of KSI’s catalysis and
possibly enzyme catalysis in general.
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Pseudosubstrate Regulation of the Type II P21-Activated Kinases (PAKs)
Titus J. Boggon.
Yale University School of Medicine, New Haven, CT, USA.
The type II p21-activated kinases (PAKs) are key effectors of RHO-family
GTPases involved in cell motility, survival and proliferation. There are two
sub-groups of PAK kinase, denoted type I (PAK1, PAK2 and PAK3) and
type II (PAK4, PAK5 and PAK6). PAK4 is the best-studied type II PAK family
member, is widely expressed, and is essential for viability in mice. PAK4 is re-
quired for oncogenic or metastatic phenotypes of many cancer cell lines, can
promote tumorigenesis and breast cancer cell migration, and is the only PAK
that is transforming when overexpressed. Furthermore, a specific PAK4 inhib-
itor (PF-3758309) has shown efficacy in mouse models of cancer. Using a struc-
ture-guided approach, we discovered that type II PAKs are regulated by an
N-terminal autoinhibitory pseudosubstrate motif centered on a critical proline
residue, and that this regulation occurs independently of activation loop phos-
phorylation. We determined 6 X-ray crystal structures of either full-length
PAK4 or its catalytic domain, that demonstrate the molecular basis for pseudo-
substrate binding to the active state with phosphorylated activation loop. We
show that full-length PAK4 is constitutively autoinhibited, but mutation of
the pseudosubstrate releases this inhibition and causes increased phosphoryla-
tion of BAD and cellular morphological changes. We also find that PAK6 is
regulated by the pseudosubstrate region, indicating a common type II PAK
autoregulatory mechanism. Finally, we find Src SH3, but not b-PIX SH3 can
activate PAK4. This clear switch-like ‘on-off’ regulation mechanism for the
type II PAKs is distinct from regulation mechanisms previously observed for
the type I PAKs. We therefore provide new understanding for type II PAK
regulation.
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When a bacterial population is subjected to environmental change, its proteome
must be re-arranged for resumption of rapid growth. Upon recurrent environ-
mental changes, rapid proteome responses are required for high average growth
rate and fitness value, suggesting high selection pressure for rapid proteome
re-arrangements in response to environmental changes. What, then, is the
best gene expression strategy for rapid proteome change among bacteria?
Here, we demonstrate that the optimal solution to the adaptation problem is to
direct all gene expression to synthesis of the proteins in the currently rate
limiting set of pathways. The result is obtained by reformulating proteome dy-
namics in terms of flow-coupled networks in which the rate limiting protein
components determine the growth rate. This approach provides a universal
frame work for the description of the whole proteome and its adaptation to
